Anthony M. Rimac - Jul 13, 2023 Form 3 Insider Report for Sagimet Biosciences Inc. (SGMT)

Role
Chief Operating Officer
Signature
/s/ Dennis Hom, Attorney-in-Fact
Stock symbol
SGMT
Transactions as of
Jul 13, 2023
Transactions value $
$0
Form type
3
Date filed
7/13/2023, 09:06 PM
Next filing
Jul 20, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding SGMT Stock Option (Right to Buy) Jul 13, 2023 Common Stock 242K $13.51 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 25% of the shares underlying this option shall vest and become exercisable on April 10, 2024, with the remainder vesting in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person's continued service on each such vesting date.

Remarks:

Exhibit 24 - Power of Attorney